Position in SRPT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,644,210
+$5,316,837 QoQ
Shares Held
703,629
+109.0% QoQ
Ownership
0.666%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 8%
None 4%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. SRPT ranks #73 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,644,210 | 703,629 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $7,327,373 | 336,736 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,859,343 | 458,148 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,556,292 | 651,598 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,746,484 | 803,888 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $37,418,812 | 586,318 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $37,791,385 | 310,810 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $34,993,552 | 280,195 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $40,352,568 | 255,396 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $29,036,711 | 224,291 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $21,619,699 | 224,201 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $24,641,357 | 203,278 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $20,929,901 | 182,762 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $26,130,498 | 189,585 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $24,992,091 | 192,870 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $20,901,564 | 189,086 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,112,784 | 161,590 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,006,447 | 179,294 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,375,041 | 159,634 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $15,486,423 | 167,457 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,595,201 | 162,017 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $13,144,259 | 176,362 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $32,820,859 | 192,509 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $26,139,078 | 186,136 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $29,266,539 | 182,528 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $18,448,949 | 188,601 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||